Phase i and II clinical trials of cancer chemopreventive agents
Ended Definitive Contract Awarded Last action
- Contract number
- 00261200309D261035160
- Awardee
-
University Of California Irvine UEI MJC5FCYQTPE6 Part of State Of California Controllers Office
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,936,398
Award facts
- Contract value 50% obligated
-
- $3,820,147.26 Current, with exercised options
- $13,886,589.26 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 11 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Irvine, CA 92697, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,063 | |
| Funding Only Action | $43,906 | |
| Other Administrative Action | -$43,906 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $846,000 | |
| Supplemental Agreement for work within scope | $750,000 | |
| Funding Only Action | $700,000 | |
| Funding Only Action | $200,000 | |
| Exercise an Option | $677,000 | |
| Exercise an Option | $752,422 | |
| Funding Only Action | $742,923 | |
| Funding Only Action | $729,752 | |
| Modification | $770,182 | |
| Original award | $770,182 |
Show all 18
About this award
This is a prime contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the University of California Irvine (UC Irvine) for Phase I and II clinical trials of cancer chemopreventive agents. The $13,886,589.26 definitive contract does not have a set-aside designation, as UC Irvine was selected based on its extensive research capabilities and expertise in biomedical sciences. The contract supports the development of novel cancer prevention therapies, leveraging UC Irvine's specialized facilities, faculty expertise, and research infrastructure. This award reflects the university's strong track record in conducting high-impact biomedical research for federal agencies like the NIH, which is a major funder of UC Irvine's grant projects in areas like Alzheimer's disease, cancer, and infectious diseases.
Quick answers
Who was awarded contract 00261200309D261035160?
00261200309D261035160 was awarded to University Of California Irvine by National Cancer Institute (National Institutes of Health) on September 30, 2003.
How much is contract 00261200309D261035160 worth?
The government has obligated $6,936,398 on 00261200309D261035160. Its current value, with exercised options, is $3,820,147. Its potential value, with all options, is $13,886,589.
Was contract 00261200309D261035160 competed?
The extent of competition for 00261200309D261035160 was full and open competition. The government received 11 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award